The Drug Safety Research Unit (DSRU) is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training Services for over 30 years.
In partnership with doctors in England, the DSRU, led by Director Professor Saad Shakir, aims to protect patients in primary and specialist care from unwanted adverse effects of newly marketed medicines using our unique methods of monitoring patients during the lifecycle of medicines.
DSRU Consultancy provides advice on strategies, study designs and options for post-marketing Pharmacovigilance, Pharmacoepidemiology and Risk Management Planning. This initiative builds on the DSRU’s vast experience in studying a wide range medicines and working with companies of all sizes.
The DSRU has an impeccable track record of providing impartial advice and has a good understanding of regulatory requirements. We offer a flexible approach, from provision of advice alone through to designing and conducting a PASS study. We may advise use of our own data sources or of other databases.
Contact Dr Liz Lynn, Head of Scientific and Educational Development (firstname.lastname@example.org) or see http://www.dsru.org/consulting-on-risk-management/View our latest news
The Drug Safety Research Unit (DSRU) offers a range of Pharmacovigilance (PV) training courses suitable for those looking for a career in pharmacovigilance, seeking career progression or in a position that requires PV knowledge and understanding. Depending on specific interests and current knowledge, the team at the DSRU is able to recommend which of our training courses could help […]View all our latest questions